SynCore Biotechnology Co.,Ltd (TPEX:4192)
20.10
+0.10 (0.50%)
Mar 4, 2026, 12:52 PM CST
TPEX:4192 Market Cap
TPEX:4192 has a market cap or net worth of 706.82 million as of March 4, 2026. Its market cap has decreased by -43.62% in one year.
Market Cap
706.82M
Enterprise Value
532.88M
Revenue
26.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.10
Market Cap Chart
Since August 29, 2013, TPEX:4192's market cap has decreased from 3.70B to 706.82M, a decrease of -80.88%. That is a compound annual growth rate of -12.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 703.30M | -19.68% |
| Dec 31, 2025 | 875.61M | -28.55% |
| Dec 31, 2024 | 1.23B | -9.24% |
| Dec 29, 2023 | 1.35B | -53.80% |
| Dec 30, 2022 | 2.92B | -20.00% |
| Dec 30, 2021 | 3.65B | -26.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lukas Biomedical | 1.12B |
| Level Biotechnology | 1.08B |
| Holy Stone Healthcare | 1.06B |
| TCI GENE | 1.01B |
| Taiwan Advance Bio-Pharmaceutical | 958.50M |
| NatureWise Biotech & Medicals | 944.75M |
| Eusol Biotech | 930.23M |
| Neith | 899.73M |